Iridex receives CE mark for Cyclo G6 laser system in Europe

Iridex has received CE mark to commercialize the Cyclo G6 laser system in Europe for the treatment of glaucoma and its symptoms, the company announced in a press release. The Cyclo G6 laser system is designed to treat a range of glaucoma diseases and features Iridex’s MicroPulse tissue-sparing technology, as well as a family of single-use probes that connect to a laser console.

Full Story →